Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
THE INCIDENCE AND INFLUENTIAL FACTORS OF DSA IN CHINESE RENAL TRANSPLANT RECIPIENTS WITH
MPA-BASED IMMUNOSUPPRESSIVE REGIMEN： A MULTI-CENTER CLINICAL STUDY (TIAIFOD STUDY)
Study procedure Investigators at participating centers will identify patients fulfilling
inclusion criteria and do not violate any exclusion criteria. Informed consent will be
obtained upon entry into the study according to national regulations. Patients will be
enrolled into the study and clinical data of patient history will be collected. Clinical data
will be collected prospectively up to a total period of 12 months.
Phase:
Phase 4
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University